A Comprehensive Immunophenotypic Marker Analysis of Hairy Cell Leukemia in Paraffin-Embedded Bone Marrow Trephine Biopsies-A Tissue Microarray Study

Hairy cell leukemia (HCL) is an uncommon B cell lymphoproliferation characterized by a unique immunophenotype. Due to low number of circulating neoplastic cells and 'dry tap' aspiration, the diagnosis is often based on BM trephine biopsy. We have performed a consecutive immunohistochemical...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Tóth Judit
Piukovics Klára
Borbényi Zita
Demeter Judit
Bagdi Enikő
Krenács László
Dokumentumtípus: Cikk
Megjelent: 2015
Sorozat:PATHOLOGY AND ONCOLOGY RESEARCH 21 No. 1
Tárgyszavak:
doi:10.1007/s12253-014-9807-5

mtmt:2738754
Online Access:http://publicatio.bibl.u-szeged.hu/25683
LEADER 02636nab a2200277 i 4500
001 publ25683
005 20221202114721.0
008 221202s2015 hu o 0|| Angol d
022 |a 1219-4956 
024 7 |a 10.1007/s12253-014-9807-5  |2 doi 
024 7 |a 2738754  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Tóth Judit 
245 1 2 |a A Comprehensive Immunophenotypic Marker Analysis of Hairy Cell Leukemia in Paraffin-Embedded Bone Marrow Trephine Biopsies-A Tissue Microarray Study  |h [elektronikus dokumentum] /  |c  Tóth Judit 
260 |c 2015 
300 |a 203-211 
490 0 |a PATHOLOGY AND ONCOLOGY RESEARCH  |v 21 No. 1 
520 3 |a Hairy cell leukemia (HCL) is an uncommon B cell lymphoproliferation characterized by a unique immunophenotype. Due to low number of circulating neoplastic cells and 'dry tap' aspiration, the diagnosis is often based on BM trephine biopsy. We have performed a consecutive immunohistochemical analysis to evaluate diagnostic usefulness of various HCL markers (CD11c, CD25, CD68, CD103, CD123, CD200, annexin A1, cyclin D1, DBA.44, HBME-1, phospho-ERK1/2, TRAP, and T-bet) currently available against fixation resistant epitopes. We analyzed tissue microarrays consisting of samples gained from 73 small B-cell lymphoma cases, including hairy cell leukemia (HCL) (n = 32), HCL variant (HCL-v) (n = 4), B-cell chronic lymphocytic leukemia (B-CLL) (n = 11), lymphoplasmacytic lymphoma (LPL) (n = 3), mantle cell lymphoma (MCL) (n = 10), splenic diffuse red pulp small B cell lymphoma (SDRPL) (n = 2), splenic B cell marginal zone lymphoma (SMZL) (n = 8), and splenic B cell lymphoma/leukemia, unclassifiable (SBCL) (n = 3) cases. The HCL cases were 100 % positive for all but 2 (DBA.44 and CD123) of these markers. Annexin A1 showed 100 % specificity and accuracy, which was followed by CD123, pERK, CD103, HBME-1, CD11c, CD25, CD68, cyclin D1, CD200, T-bet, DBA.44, and TRAP, in decreasing order. In conclusion, our results reassured the high specificity of annexin A1 and pERK, as well as the diagnostic value of standard HCL markers of CD11c, CD25, CD103, and CD123 also in paraffin-embedded BM samples. Additional markers, including HBME-1, cyclin D1, CD200, and T-bet also represent valuable tools in the differential diagnosis of HCL and its mimics. 
650 4 |a Általános orvostudomány 
700 0 1 |a Piukovics Klára  |e aut 
700 0 1 |a Borbényi Zita  |e aut 
700 0 1 |a Demeter Judit  |e aut 
700 0 1 |a Bagdi Enikő  |e aut 
700 0 1 |a Krenács László  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/25683/1/Toth-Liptak.pdf  |z Dokumentum-elérés